Strong domestic demand is set to lift pharma revenues by up to 11% in Q3FY26, though pressure from generic Revlimid in the US ...
Amid rising geopolitical tensions, Indian pharma calls for strategic overhaul of supply chain: Nandita Vijayasimha, Bengaluru Monday, January 19, 2026, 08:00 Hrs [IST] Amid rising ...
The country’s wavering stance on data exclusivity, which will allow corporations to hold a monopoly on drugs, risks global ...
In an announcement on November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) revealed the new Maximum Fair ...
In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two companion papers in JAMA, the findings are based on data from ...
AS trials suggest they can treat ever more illnesses and more people use them to slim down, it is clear weight loss jabs are ...
In 2026, significant changes to Medicare Part D will impact millions, including many Hispanics in the U.S. These adjustments, ...
The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback